MTOR and neoplasm: ADAMTS-9 acts as a functional tumor suppressor in gastric cancer through inhibiting the oncogenic AKT/mammalian target of rapamycin (mTOR) signaling pathway and ADAMTS-9 is related to beta cell function in type 2 diabetes [118].